Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
about
Ethanol extract of Portulaca Oleracea L. reduced the carbon tetrachloride induced liver injury in mice involving enhancement of NF-κB activity.Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus.Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.Current concepts of mechanisms in drug-induced hepatotoxicity.Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus.The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation.Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes.Biochemical mechanisms in drug-induced liver injury: certainties and doubts.Telmisartan ameliorates carbon tetrachloride-induced acute hepatotoxicity in rats.Kampo formula "Hochu-ekki-to" suppressed carbon tetrachloride-induced hepatotoxicity in mice.Fatal liver injury associated with clopidogrel.A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.Anti-Diabetic, Anti-Oxidant and Anti-Hyperlipidemic Activities of Flavonoids from Corn Silk on STZ-Induced Diabetic Mice.Protective effect of Trillium tschonoskii saponin on CCl4-induced acute liver injury of rats through apoptosis inhibition.
P2860
Q34978786-41D33AEB-4957-47EC-B337-64A73F04FBD1Q35089862-EC2B8241-721C-4742-9F16-2D7091F0CBE3Q35166776-1EAC2893-50D5-4158-A823-11B13EFD2C76Q36844723-148FF5D2-55C9-4606-9360-E84DB3148462Q37394799-78773EA7-7B13-469D-9830-9AC4D411CB5CQ38016232-A9A79239-54A4-454B-9BC4-C8803EAB79A3Q38101884-7EE87E75-A013-4D70-AABD-99E35FE638BEQ41121037-FF742E0E-CF07-495A-856D-8E0B5C63DA45Q41140122-9B9A1D6B-148E-4A6D-8478-57942866BC07Q42140839-E504FFA2-07E8-4C97-A5B4-A2919118BDFDQ42145594-C58CB1B5-390A-4535-92DA-2D0430508688Q42588200-9537BB02-62C8-4C82-B13F-80BC5540E9C5Q42699305-49158EE8-2AE2-4453-BF54-1DACBB162B05Q42749473-8D18DADF-6A5B-425B-93BD-6EB1BD03AF48Q43246908-13C5C4D2-ED31-4021-95DE-47ABA49FF5C2Q46942307-0357C925-CCCD-4EE6-8C18-66727F8F24D9Q51592474-15DA77F9-FFCE-4A86-B255-1096BC21BD90Q51822077-DDFDC24D-D420-4BE4-B7AE-B49C8A784130
P2860
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
@en
type
label
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
@en
prefLabel
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
@en
P2093
P2860
P1476
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes.
@en
P2093
P2860
P304
P356
10.1080/10408440701215100
P407
P577
2007-06-01T00:00:00Z